Selective serotonin reuptake inhibitor and serotonin‐norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitor and serotonin‐norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series

Published:2021-12-27 Issue: Volume: Page:
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Aust J Dermatology

Author:

Masuka Josiah T¹²^ORCID,Mchunu Nobuhle²³⁴^ORCID,Mkhize Zamambo¹^ORCID,Thandar Yasmeen⁵^ORCID,Mosam Anisa¹^ORCID

Affiliation:

1. Department of Dermatology Nelson R Mandela School of Medicine University of KwaZulu‐Natal DurbanSouth Africa

2. Centre for the AIDS Programme of Research in South Africa (CAPRISA) University of KwaZulu‐Natal DurbanSouth Africa

3. Biostatistics Research Unit South African Medical Research Council DurbanSouth Africa

4. School of Mathematics, Statistics and Computer Science University of KwaZulu‐Natal PietermaritzburgSouth Africa

5. Department of Basic Medical Sciences Faculty of Heath Sciences Durban University of Technology Durban South Africa

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13780

Reference39 articles.

1. National Institute for Health and Care Excellence (NICE).Depression in adults: recognition and management ‐ Clinical guideline CG90. Update 2018 ed. London: NICE;2009.

2. SSRI Antidepressant Medications

3. Off‐label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system;Wong J;BMJ,2017

4. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison;Sansone RA;Innov. Clin. Neurosci.,2014

5. Mechanism of action of antidepressant medications;Feighner J;J. Clin. Psychiatry.,1999